IBNAi Client Partners

Actionable Market Intel

Decoding the Balance of Power between Bulls and Bears AI, Algorithms, Insights and Answers for Investors

IBN Spotlight Company

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

Nutriband Inc. is a U.S.-based pharmaceutical company specializing in the development of innovative transdermal drug delivery systems. The company’s core focus is to enhance patient outcomes by utilizing advanced drug delivery technologies, specifically targeting the global opioid epidemic. By integrating aversive agents into transdermal patches, Nutriband aims to prevent the abuse, misuse, diversion, and accidental exposure of drugs with high abuse potential, such as fentanyl.

IBN Spotlight Company

TransCode Therapeutics Inc. (NASDAQ: RNAZ)

TransCode Therapeutics Inc. (NASDAQ: RNAZ) is a clinical-stage biotechnology company developing RNA-based therapeutics intended to overcome the lethal challenges of metastatic cancer. By targeting the molecular underpinnings of metastasis with a novel delivery platform, TransCode aims to open new frontiers in cancer treatment.

IBN Spotlight Company

Actinium Pharmaceuticals Inc. (NYSE American: ATNM)

Actinium Pharmaceuticals Inc. is a pioneering biotechnology company focused on the development of targeted radiotherapies that aim to deliver precision treatment for hematologic malignancies.

IBN Spotlight Company

Capstone Holding Corp. (NASDAQ: CAPS)

Capstone Holding Corp. is a building products distribution company that has expanded through both organic growth and strategic acquisitions. The company leverages the distribution backbone of its operating subsidiary, Instone, which services 31 U.S. states, to create a value-added platform for further acquisitions.

IBN Spotlight Company

Nutriband Inc. (NASDAQ: NTRB)

Nutriband Inc. is a U.S.-based pharmaceutical company specializing in the development of innovative transdermal drug delivery systems. The company’s core focus is to enhance patient outcomes by utilizing advanced drug delivery technologies, specifically targeting the global opioid epidemic. By integrating aversive agents into transdermal patches, Nutriband aims to prevent the abuse, misuse, diversion, and accidental exposure of drugs with high abuse potential, such as fentanyl.

IBN Spotlight Company

Surf Air Mobility Inc. (NYSE: SRFM)

Surf Air Mobility Inc. is a pioneering electric aviation and air travel company focused on expanding regional air mobility through the power of electrification. By developing hybrid and fully electric aircraft, the company aims to make air travel more accessible, cost-effective, and environmentally sustainable. Its innovative approach combines electrification technology with existing aviation infrastructure to accelerate the adoption of low-emission regional flights.

IBN Spotlight Company

Rezolve Ai Ltd. (NASDAQ: RZLV)

Rezolve Ai Ltd. is a leading technology company at the forefront of Conversational AI, transforming digital retail engagement with its proprietary artificial intelligence solutions. The company’s platform integrates advanced large language models (“LLMs”) to enhance eCommerce interactions, providing businesses with AI-powered search, checkout, and virtual assistance capabilities. By leveraging cutting-edge AI, Rezolve Ai aims to streamline customer journeys, increase conversions, and drive revenue growth for merchants worldwide.

IBN Spotlight Company

Smartkem Inc. (NASDAQ: SMTK)

Smartkem Inc. is transforming the electronics industry with its pioneering organic thin-film transistors (“OTFTs”), which are set to revolutionize next-generation display technology. The company’s patented TRUFLEX® semiconductor and dielectric inks, also known as liquid electronic polymers, enable the development of high-performance, low-cost displays through low-temperature printing processes. These inks integrate seamlessly with existing manufacturing infrastructure, facilitating the production of displays that surpass traditional models in efficiency and performance.

IBN Spotlight Company

Pineapple Financial Inc. (NYSE American: PAPL)

Pineapple Financial Inc. is a pioneering fintech transforming Canada’s mortgage brokerage industry. By integrating cutting-edge cloud-based tools with AI-driven systems, Pineapple redefines how brokers assist Canadians in achieving homeownership. The company emphasizes broker success and homeowner satisfaction, fostering a collaborative ecosystem built for long-term impact.

IBN Spotlight Company

Eco Wave Power Global (NASDAQ: WAVE)

Eco Wave Power Global is a pioneering renewable energy company that harnesses the immense power of ocean and sea waves through its patented, cost-effective onshore technology. By integrating wave energy systems with existing infrastructure, the company minimizes environmental impacts while delivering scalable and sustainable electricity solutions. Its innovative approach positions it as a leader in the clean energy sector, addressing global energy challenges with advanced technology.

IBN Spotlight Company

SKYX Platforms Corp. (NASDAQ: SKYX)

SKYX Platforms Corp. (d/b/a Sky Technologies) is on a mission to revolutionize homes and buildings by integrating safe, advanced, and smart technologies. With electricity being a constant in every building, SKYX aims to make safety and intelligence the new standard. The company has developed disruptive platform technologies, secured by over 94 U.S. and global patents and patent-pending applications. SKYX emphasizes cutting-edge safety features that elevate user experience through smart home and building solutions.

IBN Spotlight Company

Greenwave Technology Solutions Inc. (NASDAQ: GWAV)

Greenwave Technology Solutions Inc., through its wholly owned subsidiary Empire Services Inc., operates a network of 13 metal recycling facilities located across Virginia, North Carolina, and Ohio. These facilities specialize in the collection, classification, and processing of raw scrap metal, both ferrous and nonferrous. By efficiently managing and repurposing scrap metal, Greenwave plays a crucial role in the recycling industry, contributing to the sustainability and conservation of natural resources.

IBN Spotlight Company

Datavault AI Inc. (NASDAQ: DVLT)

Datavault AI Inc. (NASDAQ: DVLT) is a Web 3.0 infrastructure company advancing AI-driven data monetization, valuation, and tokenization technologies across both public and private sector applications. Through a combination of proprietary platforms, high-performance computing, and patent-protected solutions, the company enables enterprises, institutions, and governments to extract meaningful value from their data while ensuring regulatory compliance, identity security, and scalability.

IBN Spotlight Company

Telomir Pharmaceuticals Inc. (NASDAQ: TELO)

Telomir Pharmaceuticals Inc. is a pre-clinical-stage pharmaceutical company focused on developing and commercializing Telomir-1, a groundbreaking small molecule designed to lengthen DNA’s protective telomere caps. Telomeres, the end caps of chromosomes, play a crucial role in protecting DNA from degradation, but they naturally shorten as humans and animals age, contributing to the onset of degenerative and age-related diseases. By targeting telomere lengthening, Telomir-1 has the potential to address these conditions and promote longevity, with applications for both humans and pets.

IBN Spotlight Company

NanoViricides Inc. (NYSE American: NNVC)

NanoViricides Inc. is a clinical stage global leader in the development of nanomedicine drugs against viruses. Going beyond what antibodies and immunotherapeutics do, the company’s unique nanoviricide® platform technology is designed to specifically target and dismantle enveloped virus particles, offering a novel approach to treating a wide range of viral infections. NanoViricides' lead drug candidate, NV-387, is being developed for the treatment of respiratory viral infections, including RSV, COVID-19, Long COVID, and Influenza, with the company currently advancing NV-387 into Phase II human clinical trials. Another advanced candidate, NV-HHV-1, targets Shingles and represents a significant step forward in the treatment of viral diseases.

IBN Spotlight Company

Gaxos.ai Inc. (NASDAQ: GXAI)

Gaxos.ai Inc. is revolutionizing the human-AI relationship, pushing the boundaries of artificial intelligence to offer solutions that resonate on a human level. The company's mission extends beyond application development; it aims to integrate AI into various aspects of human existence, transforming how people interact with technology. With a strong commitment to enhancing quality of life, Gaxos.ai focuses on creating AI-driven solutions that address health, longevity, and entertainment, making advanced technology accessible and beneficial to all.

IBN Spotlight Company

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)

Tonix Pharmaceuticals Holding Corp. is a fully-integrated biopharmaceutical company dedicated to developing, licensing, and commercializing innovative therapeutics aimed at treating and preventing human diseases and alleviating suffering. The company's development portfolio is primarily focused on central nervous system (CNS) disorders, with its lead product candidate, TNX-102 SL, showing significant promise for the management of fibromyalgia. With two successful Phase 3 studies completed, Tonix is preparing to submit a New Drug Application (NDA) to the FDA in the second half of 2024 for TNX-102 SL, which has also been granted Fast Track designation. In addition to fibromyalgia, TNX-102 SL is being developed to treat acute stress reactions, further broadening its therapeutic potential.

IBN Spotlight Company

Silo Pharma Inc. (NASDAQ: SILO)

Silo Pharma Inc. is a cutting-edge biopharmaceutical company focused on developing novel therapeutics to address underserved medical conditions, particularly in the fields of stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The company is at the forefront of integrating conventional drug therapies with innovative psychedelic treatments, utilizing advanced formulations and drug delivery systems to enhance efficacy and patient outcomes. Through strategic collaborations with universities and independent laboratories, Silo Pharma is pioneering a new era in biopharmaceutical research and development.

IBN Spotlight Company

Oragenics Inc. (NYSE American: OGEN)

Oragenics Inc. is a development-stage biotechnology company pioneering innovative solutions in pharmaceutical medications, with a focus on nasal delivery systems. The company addresses critical unmet medical needs in neurology and infectious diseases, with research centered on developing drug candidates for mild traumatic brain injuries, such as concussions, and rare neurodegenerative disorders like Niemann-Pick Disease Type C. These areas represent significant challenges within the medical community due to limited treatment options making Oragenics' mission especially impactful.

During the last 20+ years IBN has represented over 600 public and private companies across multiple industries and sectors. Corporations large and small have chosen IBN’s platform services for unparalleled visibility and recognition utilizing our proprietary CORE Relations Solutions, Brand Awareness, Corporate Communications and Social Media Solutions.

IBNAi unique platform solutions assist companies build or reposition their brands, launch new products and services, support uplistings, and prepare for major corporate milestones such as initial public offerings, mergers and acquisitions.

From private start-ups to established public companies, IBNAi client partners rely on our integrated support and technology-driven communications systems to strengthen visibility and market awareness. Our proprietary strategies and expansive platform are designed to cut through market noise, reach targeted audiences, and engage highly relevant investor demographics.

IBNAi is committed to delivering measurable value and results that consistently exceed client expectations.

IBN Client Partner Index IBN Client Partners – Past & Present

Press Release Distribution with InvestorWire

InvestorWire represents an expansive network of wire services to ensure the best distribution of your news to ever-expanding audiences. Our network of distribution points enables clients to rise above the commotion and reach all target markets, industries and demographics.

Choose a press release coverage package that fits your need.

* Meets news distribution requirements for dual-listed entities.

InvestorBrandNetwork Client

Writer On Computer

Account Executive on Phone

AudioPressRelease Production

Woman Listening to AudioPressRelease

Cannabis Focused Distribution - Hemp CBD Oil

Man producing AudioPressRelease

Enhance your press release coverage with InvestorWire’s specialty solutions.

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.